Cost-Efectiveness of Delayed-Release Dimethyl Fumarate Compared to Glatiramer Acetate and Fingolimod for the Treatment of Relapsing-Remiting Multiple Sclerosis

Mauskopf, J., Fay, M., Iyer, R., & Livingston, T. (2014). Cost-Efectiveness of Delayed-Release Dimethyl Fumarate Compared to Glatiramer Acetate and Fingolimod for the Treatment of Relapsing-Remiting Multiple Sclerosis. Value in Health, 17(3), A60-A61.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

View All Experts
Navigate to Josephine A. Mauskopf

Josephine A. Mauskopf